Our Science
Disruptive Science, New Therapeutic Possibilities
At Endeavor BioMedicines, we believe the greatest medical challenges demand more than incremental improvements; they require bold solutions that unlock the possibility of truly disruptive and positive change.
Endeavor’s investigational candidate, taladegib, offers a novel approach to potentially disrupt the underlying mechanisms that cause fibrotic lung disease.
